UK Pharmaceutical Regulatory Affairs Market Size & Outlook
UK pharmaceutical regulatory affairs market, 2018-2030 (US$M)
Related Markets
UK pharmaceutical regulatory affairs market highlights
- The UK pharmaceutical regulatory affairs market generated a revenue of USD 206.8 million in 2023 and is expected to reach USD 344.8 million by 2030.
- The UK market is expected to grow at a CAGR of 7.6% from 2024 to 2030.
- In terms of segment, regulatory writing & publishing was the largest revenue generating services in 2023.
- Legal Representation is the most lucrative services segment registering the fastest growth during the forecast period.
Pharmaceutical regulatory affairs market data book summary
| Market revenue in 2023 | USD 206.8 million |
| Market revenue in 2030 | USD 344.8 million |
| Growth rate | 7.6% (CAGR from 2023 to 2030) |
| Largest segment | Regulatory writing & publishing |
| Fastest growing segment | Legal Representation |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Regulatory Consulting, Legal Representation, Regulatory Writing & Publishing, Product Registration & Clinical Trial Applications, Other Services |
| Key market players worldwide | Labcorp Holdings Inc, IQVIA Holdings Inc, Icon PLC, Wuxi AppTec Co Ltd, Charles River Laboratories International Inc, Cencora Inc, Pharmexon, Genpact Ltd, Freyr Solutions, PAREXEL |
Other key industry trends
- In terms of revenue, UK accounted for 4.1% of the global pharmaceutical regulatory affairs market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK pharmaceutical regulatory affairs market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 344.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pharmaceutical Regulatory Affairs Market Scope
Pharmaceutical Regulatory Affairs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK pharmaceutical regulatory affairs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical regulatory affairs market will help companies and investors design strategic landscapes.
Regulatory writing & publishing was the largest segment with a revenue share of 36.56% in 2023. Horizon Databook has segmented the UK pharmaceutical regulatory affairs market based on regulatory consulting, legal representation, regulatory writing & publishing, product registration & clinical trial applications, other services covering the revenue growth of each sub-segment from 2018 to 2030.
The UK accounts for 10.0% of global pharmaceutical R&D and ranks third globally, followed by the U.S. and Japan. The demand for generic products has also increased owing to the government’s support for generics over branded drugs.
This trend attracts small- and mid-size biopharmaceuticals and medical device companies to enter the UK market, thereby improving the demand for regulatory support services.
Reasons to subscribe to UK pharmaceutical regulatory affairs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK pharmaceutical regulatory affairs market databook
-
Our clientele includes a mix of pharmaceutical regulatory affairs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK pharmaceutical regulatory affairs market , including forecasts for subscribers. This country databook contains high-level insights into UK pharmaceutical regulatory affairs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UK pharmaceutical regulatory affairs market size, by services, 2018-2030 (US$M)
UK Pharmaceutical Regulatory Affairs Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
